Skip to main content
Erschienen in: Supportive Care in Cancer 1/2006

01.01.2006 | Original Article

Edmonton symptom assessment scale: Italian validation in two palliative care settings

verfasst von: Cecilia Moro, Cinzia Brunelli, Guido Miccinesi, Mauro Fallai, Piero Morino, Massimo Piazza, Roberto Labianca, Carla Ripamonti

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2006

Einloggen, um Zugang zu erhalten

Abstract

In the palliative care setting, the Edmonton Symptom Assessment Scale (ESAS) was developed for use in daily symptom assessment of palliative care patients. ESAS considers the presence and severity of nine symptoms common in cancer patients: pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, well-being and shortness of breath plus an optional tenth symptom, which can be added by the patient. The aim of this study was to validate the Italian version of ESAS and to evaluate an easy quality of life monitoring system that uses a patient’s self-rating symptom assessment in two different palliative care settings: in-patients and home patients. Eighty-three in-patients and 158 home care patients were enrolled. In the latter group, the Italian validated version of the Symptom Distress Scale (SDS) was also administered at the admission of the patients. The two groups of patients have similar median survival, demographic and clinical characteristics, symptom prevalence and overall distress score at baseline. ESAS shows a good concurrent validity with respect to SDS. The correlation between the physical items of ESAS and SDS was shown to be higher than the correlation between the psychological items. The association of ESAS scores and performance status (PS) showed a trend: the higher the symptom score was, the worse was the PS level. Test–retest evaluation, applied in the in-patient group, showed good agreement for depression, well-being and overall distress and a moderate agreement for all the other items. In conclusion, ESAS can be considered a valid, reliable and feasible instrument for physical symptom assessment in routine “palliative care” clinical practice with a potentially different responsiveness in different situations or care settings.
Literatur
1.
Zurück zum Zitat Finlay IG, Dunlop R (1994) Quality of life assessment in palliative care. Ann Oncol 5:13–18 Finlay IG, Dunlop R (1994) Quality of life assessment in palliative care. Ann Oncol 5:13–18
2.
Zurück zum Zitat Gough IR, Furnival CM, Schilder L, Grove W (1983) Assessment of quality of life of patients with advanced cancer. Eur J Cancer Clin Oncol 19:1161–1165 Gough IR, Furnival CM, Schilder L, Grove W (1983) Assessment of quality of life of patients with advanced cancer. Eur J Cancer Clin Oncol 19:1161–1165
3.
Zurück zum Zitat Cohen SR, Mounth BM (1992) Quality of life in terminal illness: defining and measuring subjective well-being in the dying. J Palliat Care 3:40–45 Cohen SR, Mounth BM (1992) Quality of life in terminal illness: defining and measuring subjective well-being in the dying. J Palliat Care 3:40–45
4.
Zurück zum Zitat Hopwood P (1992) Progress, problems and priorities in quality of life research. Eur J Cancer 28A(10):1748–1752CrossRefPubMed Hopwood P (1992) Progress, problems and priorities in quality of life research. Eur J Cancer 28A(10):1748–1752CrossRefPubMed
5.
Zurück zum Zitat Aaronson NK, Bullinger M, Ahmedzai S (1988) A modular approach to quality of life assessment in cancer clinical trials. Recent Results Cancer Res 111:231–249PubMed Aaronson NK, Bullinger M, Ahmedzai S (1988) A modular approach to quality of life assessment in cancer clinical trials. Recent Results Cancer Res 111:231–249PubMed
6.
Zurück zum Zitat Ferrel BR, Wisdom C, Wenzel C (1989) Quality of life as an outcome variable in the management of cancer pain. Cancer 63(11 Suppl):2321–2327 Ferrel BR, Wisdom C, Wenzel C (1989) Quality of life as an outcome variable in the management of cancer pain. Cancer 63(11 Suppl):2321–2327
7.
Zurück zum Zitat Slevin ML, Plant H, Lynch D, Drinkwater J, Gergory WM (1988) Who should measure quality of life: the doctor or the patient? Br J Cancer 57:109–112 Slevin ML, Plant H, Lynch D, Drinkwater J, Gergory WM (1988) Who should measure quality of life: the doctor or the patient? Br J Cancer 57:109–112
8.
Zurück zum Zitat Padilla GV, Ferrel B, Grant MM et al (1990) Defining the content of domain of quality of life for cancer patients with pain. Cancer Nurs 13(2):108–115PubMed Padilla GV, Ferrel B, Grant MM et al (1990) Defining the content of domain of quality of life for cancer patients with pain. Cancer Nurs 13(2):108–115PubMed
9.
Zurück zum Zitat McEvoy MD, McCorkle R (1990) Quality of life issues in patients with disseminated breast cancer. Cancer 66(6 Suppl):1416–1421 McEvoy MD, McCorkle R (1990) Quality of life issues in patients with disseminated breast cancer. Cancer 66(6 Suppl):1416–1421
10.
Zurück zum Zitat Bliss JM, Selby PJ, Robertson B et al (1992) A method of assessing quality of life of cancer patients: replication of the factor structure. Br J Cancer 65(6):961–966 Bliss JM, Selby PJ, Robertson B et al (1992) A method of assessing quality of life of cancer patients: replication of the factor structure. Br J Cancer 65(6):961–966
11.
Zurück zum Zitat Grant MM, Padilla GV, Ferrel BR et al (1990) Assessment of quality of life with a single instrument. Semin Oncol Nurs 6(4):260–270PubMed Grant MM, Padilla GV, Ferrel BR et al (1990) Assessment of quality of life with a single instrument. Semin Oncol Nurs 6(4):260–270PubMed
12.
Zurück zum Zitat Maguire P, Selby P (1989) Assessing quality of life in cancer patients. Br J Cancer 60(3):437–440PubMed Maguire P, Selby P (1989) Assessing quality of life in cancer patients. Br J Cancer 60(3):437–440PubMed
13.
Zurück zum Zitat Caraceni A, Cherny N et al (2002) Pain measurement tools and methods in clinical research in palliative care: recommendation of an expert working group of the European Association of Palliative Care. J Pain Symptom Manage 23:239–255CrossRefPubMed Caraceni A, Cherny N et al (2002) Pain measurement tools and methods in clinical research in palliative care: recommendation of an expert working group of the European Association of Palliative Care. J Pain Symptom Manage 23:239–255CrossRefPubMed
14.
Zurück zum Zitat Aaronson NK (1986) Methodological issues in psychosocial oncology with special reference to clinical trials. In: Ventafridda V, van Dam F, Yanick R et al (eds) Assessment of quality of life and cancer treatment. Elsevier, Amsterdam, pp 29–41 Aaronson NK (1986) Methodological issues in psychosocial oncology with special reference to clinical trials. In: Ventafridda V, van Dam F, Yanick R et al (eds) Assessment of quality of life and cancer treatment. Elsevier, Amsterdam, pp 29–41
15.
Zurück zum Zitat Schipper H, Clinch J et al (1984) Measuring the quality of life of cancer patients: the functional living index-cancer: development and validation. J Clin Oncol 2:472–483PubMed Schipper H, Clinch J et al (1984) Measuring the quality of life of cancer patients: the functional living index-cancer: development and validation. J Clin Oncol 2:472–483PubMed
16.
Zurück zum Zitat Tamburini M, Rosso S et al (1992) A therapy impact questionnaire for quality of life assessment in advanced cancer research. Ann Oncol 3:565–570PubMed Tamburini M, Rosso S et al (1992) A therapy impact questionnaire for quality of life assessment in advanced cancer research. Ann Oncol 3:565–570PubMed
17.
Zurück zum Zitat Bruera E, Kuehn N, Miller M et al (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6–9PubMed Bruera E, Kuehn N, Miller M et al (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6–9PubMed
18.
Zurück zum Zitat Higginson I, Wade AM et al (1992) Effectiveness of two palliative support teams. J Public Health Med 14:50–56PubMed Higginson I, Wade AM et al (1992) Effectiveness of two palliative support teams. J Public Health Med 14:50–56PubMed
19.
Zurück zum Zitat Bruera E, MacDonald S (1993) Audit methods the edmonton symptom assessment system. In: Higginson I (ed) Clinical audit in palliative care. Radcliffe Medical, Oxford, pp 61–77 Bruera E, MacDonald S (1993) Audit methods the edmonton symptom assessment system. In: Higginson I (ed) Clinical audit in palliative care. Radcliffe Medical, Oxford, pp 61–77
20.
Zurück zum Zitat Philip J et al (1998) Concurrent validity of the modified Edmonton Symptom Assessment Scale (ESAS) with the Rotterdam Symptom Checklist and the Brief Pain Inventory. Support Care Cancer 6:539–541 Philip J et al (1998) Concurrent validity of the modified Edmonton Symptom Assessment Scale (ESAS) with the Rotterdam Symptom Checklist and the Brief Pain Inventory. Support Care Cancer 6:539–541
21.
Zurück zum Zitat Rees E et al (1998) The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK. Palliat Med 12:75–82CrossRefPubMed Rees E et al (1998) The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK. Palliat Med 12:75–82CrossRefPubMed
22.
Zurück zum Zitat Dudgeon D et al (1999) The Edmonton Symptom Assessment Scale as an audit tool. J Palliat Care 15(3):14–19PubMed Dudgeon D et al (1999) The Edmonton Symptom Assessment Scale as an audit tool. J Palliat Care 15(3):14–19PubMed
23.
Zurück zum Zitat Chang V et al (2000) Validation of the Edmonton Symptom Assessment Scale. Cancer 88:2164–2171 Chang V et al (2000) Validation of the Edmonton Symptom Assessment Scale. Cancer 88:2164–2171
24.
Zurück zum Zitat Heedman P et al (2001) Symptom assessment in advanced palliative home care for cancer patients using the ESAS: clinical aspects. Anticancer Res 21:4077–4082 Heedman P et al (2001) Symptom assessment in advanced palliative home care for cancer patients using the ESAS: clinical aspects. Anticancer Res 21:4077–4082
25.
Zurück zum Zitat Strômgren A et al (2002) Self assessment in cancer patients referred to palliative care. Cancer 94:512–520 Strômgren A et al (2002) Self assessment in cancer patients referred to palliative care. Cancer 94:512–520
26.
Zurück zum Zitat Nekolaichuk CL, Bruera E (1999) A comparison of patients and proxy symptom assessments in advanced cancer patients. Palliat Med 13:311–323CrossRefPubMed Nekolaichuk CL, Bruera E (1999) A comparison of patients and proxy symptom assessments in advanced cancer patients. Palliat Med 13:311–323CrossRefPubMed
27.
Zurück zum Zitat McCorkle R, Young K (1978) Development of a Symptom Distress Scale. Cancer Nurs 1:373–378PubMed McCorkle R, Young K (1978) Development of a Symptom Distress Scale. Cancer Nurs 1:373–378PubMed
28.
Zurück zum Zitat Sze FK, Chung TK (1998) Pain in Chinese cancer patients under palliative care. Palliat Med 12:271–278CrossRefPubMed Sze FK, Chung TK (1998) Pain in Chinese cancer patients under palliative care. Palliat Med 12:271–278CrossRefPubMed
29.
Zurück zum Zitat Deloach LJ, Higgins MS (1998) The visual analog scale in the immediate postoperative period: intrasubject variability and correlation with a numerical scale. Anesth Analg 86:102–106CrossRefPubMed Deloach LJ, Higgins MS (1998) The visual analog scale in the immediate postoperative period: intrasubject variability and correlation with a numerical scale. Anesth Analg 86:102–106CrossRefPubMed
30.
Zurück zum Zitat Giorgi F, Cellerino R (1996) Assessing quality of life in patients with cancer: a comparison of visual analogue and a categorical mode. Am J Clin Oncol 19:394–399CrossRefPubMed Giorgi F, Cellerino R (1996) Assessing quality of life in patients with cancer: a comparison of visual analogue and a categorical mode. Am J Clin Oncol 19:394–399CrossRefPubMed
31.
Zurück zum Zitat Peruselli C et al (1993) Quality of life assessment in a home care program for advanced cancer patients: a study using the Symptom Distress Scale. J Pain Symptom Manage 8:306–311CrossRefPubMed Peruselli C et al (1993) Quality of life assessment in a home care program for advanced cancer patients: a study using the Symptom Distress Scale. J Pain Symptom Manage 8:306–311CrossRefPubMed
32.
Zurück zum Zitat Fayers PM, Machin D (2000) Quality of life assessment analysis and interpretation. Wiley, New York (hard cover) Fayers PM, Machin D (2000) Quality of life assessment analysis and interpretation. Wiley, New York (hard cover)
33.
Zurück zum Zitat Higginson I et al (1990) Palliative care: views of patients and their families. BMJ 301:277–281PubMed Higginson I et al (1990) Palliative care: views of patients and their families. BMJ 301:277–281PubMed
34.
Zurück zum Zitat Peruselli C et al (1997) Outcome evaluation in a home palliative care service. J Pain Symptom Manage 13:158–165CrossRefPubMed Peruselli C et al (1997) Outcome evaluation in a home palliative care service. J Pain Symptom Manage 13:158–165CrossRefPubMed
35.
Zurück zum Zitat Schwartz CE et al (2004) Reconsidering the psychometrics of quality of life assessment in light of response shift and appraisal. Health Qual Life Outcomes 2:16CrossRefPubMed Schwartz CE et al (2004) Reconsidering the psychometrics of quality of life assessment in light of response shift and appraisal. Health Qual Life Outcomes 2:16CrossRefPubMed
36.
Zurück zum Zitat Heedman PA, Strang P (2003) Pain and pain alleviation in hospital-based home care: demographic, biological and treatment factors. Support Care Cancer 11:35–40 Heedman PA, Strang P (2003) Pain and pain alleviation in hospital-based home care: demographic, biological and treatment factors. Support Care Cancer 11:35–40
37.
Zurück zum Zitat Stromgren AS, Groenvold M (2002) Symptomatology of cancer patients in palliative care: content validation of self-assessment questionnaires against medical records. Eur J Cancer 38:788–794 Stromgren AS, Groenvold M (2002) Symptomatology of cancer patients in palliative care: content validation of self-assessment questionnaires against medical records. Eur J Cancer 38:788–794
38.
Zurück zum Zitat Fisch MJ, Titzer ML (2003) Assessment of quality of life in outpatients with advanced cancer: the accuracy of clinician estimation and the relevance of spiritual well being—a Hoosier Oncology Group study. J Clin Oncol 21:2754–2759CrossRefPubMed Fisch MJ, Titzer ML (2003) Assessment of quality of life in outpatients with advanced cancer: the accuracy of clinician estimation and the relevance of spiritual well being—a Hoosier Oncology Group study. J Clin Oncol 21:2754–2759CrossRefPubMed
39.
Zurück zum Zitat MacClain CS, Rosenfeld B (2003) Effect of spiritual well-being on end of life despair in terminally ill cancer patients. Lancet 361:1603–1607CrossRefPubMed MacClain CS, Rosenfeld B (2003) Effect of spiritual well-being on end of life despair in terminally ill cancer patients. Lancet 361:1603–1607CrossRefPubMed
Metadaten
Titel
Edmonton symptom assessment scale: Italian validation in two palliative care settings
verfasst von
Cecilia Moro
Cinzia Brunelli
Guido Miccinesi
Mauro Fallai
Piero Morino
Massimo Piazza
Roberto Labianca
Carla Ripamonti
Publikationsdatum
01.01.2006
Erschienen in
Supportive Care in Cancer / Ausgabe 1/2006
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-005-0834-3

Weitere Artikel der Ausgabe 1/2006

Supportive Care in Cancer 1/2006 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.